| Financial Year |
March 31 2023 |
| Monetary Funds |
2,216,936,866.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,736,268.21 |
| Accounts Receivable |
1,111,593,963.24 |
| Advances to Suppliers |
26,728,467.32 |
| Other Receivables |
143,050,867.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
995,354,012.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,446,261.42 |
| Total Current Assets |
4,566,071,588.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,041,638.22 |
| Investment Properties |
-- |
| Fixed Assetes |
209,182,994.58 |
| Under-construction Projects |
97,920,354.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
606,976,080.22 |
| R&D expenses |
103,360,181.33 |
| Goodwill |
1,003,737,212.80 |
| Long-Term Deferred and Prepaid Expenses |
5,616,507.15 |
| Deferred Income Tax Assets |
223,249,568.88 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,487,107,334.20 |
| Total Assets |
7,053,178,922.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
500,502,277.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,735,519.68 |
| Taxes Payable |
6,006,958.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
112,465,461.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,119,728.32 |
| Other Current Liabilities |
3,860,910.24 |
| Sub-Total of Current Liabilities |
1,321,484,479.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,362,726.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,545,484.88 |
| Total Liabilities |
1,351,029,964.45 |
| Paid-In Capital(Or Share Stock) |
824,561,023.00 |
| Capital Surplus |
3,282,745,034.25 |
| Surplus Reserve |
102,450,598.17 |
| LESS:Treasury Stock |
132,418,759.75 |
| Undistributed Profits |
1,518,508,823.39 |
| Minority Stockholder's Interest |
120,872,339.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,581,276,619.06 |
| Owner's Equity（Stockholder's Equity） |
5,702,148,958.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,053,178,922.77 |
